MGM
MGM Resorts International
$28.90
+1.51% 2026-10-20
Consumer DiscretionaryS&P 500
MGMSPY
1W
-1.7%
1M
-23.6%
3M
-36.7%
6M
-26.1%
YTD
-20.8%
1Y
-9.3%
Live chart
Loading live chart…
Grades vs sector
Momentum48th pct in sectorC+
Momentum
48th pct in sector
12-1 return: -3.1%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Growth32nd pct in sectorC-
Growth
32nd pct in sector
Revenue growth (YoY): +1.0%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Value32nd pct in sectorC-
Value
32nd pct in sector
Forward E/P: 6.7% · EBITDA/EV: 6.3%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Profitability39th pct in sectorC-
Profitability
39th pct in sector
Profit margin: +2.4% · Return on equity: +18.9%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Quality Growth
not ranked (outside this model's universe or screens)
Momentum Top 15rank 184 of 499 · 12-1 momentum % 19.3
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More newsKey stats
Market cap$7.4B
P/E (trailing)17.8
P/E (forward)15.8
52-week range27.94 – 51.59
Revenue growth (YoY, latest qtr)+1.0%
Dividend yield0.00%
Analyst consensusBuy (19)
Mean price target$43.68 (+51%)
Valuation and fundamentals
Valuation & fundamentals
Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +1 (DCF counts double).
▲DCF (base case)above the price by 131%
▼Forward P/E vs sector15.8x vs median 13.4x
•Piotroski F-score6/9
▼Altman Z0.8 (distress)
•Net debt / EBITDA2.0x
▲Analyst target+51% (19 analysts)
Discounted cash flow
Bear
$39
+34%
growth 1% · disc. 12.0% · term. 2.0%
Base
$67
+131%
growth 6% · disc. 11.0% · term. 2.5%
Bull
$101
+248%
growth 9% · disc. 10.0% · term. 3.0%
A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price implies shrinking cash flows: about -4% a year for 10 years.
Implied
-4%/yr
FCF, last 3 yrs
+14%/yr
FCF, last 5 yrs
n/a
Revenue, last 3 yrs
+10%/yr
Revenue, last 5 yrs
+28%/yr
Same inputs as the DCF above: trailing free cash flow 1.5B, 11.0% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.35 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs Consumer Discretionary
P/E (trailing)
pricier
sector median 17.7× · 51st pct
17.8×pricier
Forward P/E
pricier
sector median 13.4× · 65th pct
15.8×pricier
EV / EBITDA
cheaper
sector median 11.3× · 4th pct
5.5×cheaper
Price / sales
cheaper
sector median 1.2× · 17th pct
0.4×cheaper
Price / book
pricier
sector median 2.8× · 52nd pct
2.9×pricier
FCF yield
cheaper
sector median 6.6% · 92nd pct
20.2%cheaper
Forward EPS $1.83 vs trailing $1.62 (+13% expected growth). Forward P/E uses analysts' next-12-month estimate.
Quality & financial health
Gross margin
–
Operating margin
5.7%
FCF margin
8.4%
Net margin
2.4%
Return on equity
16.9%
Return on invested capital
15.2%
Net debt / EBITDA
2.0×
Current ratio
1.3×
Interest cover
2.5×
Cash conversion (OCF/NI)
5.8×
Piotroski F-score 6/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✗ Gross margin improved✓ Asset turnover improved
Altman Z-score 0.8 (distress zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$44
+51%
Analysts
19
Buy
Range
$29–$57
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $17.5B | $205.9M | $1.5B |
| 2024 | $17.2B | $746.6M | $1.2B |
| 2023 | $16.2B | $1.1B | $1.8B |
| 2022 | $13.1B | $1.5B | $991.4M |
| 2021 | $9.7B | $1.3B | $882.7M |
| 2020 | $5.2B | $-1.0B | $-1.8B |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +10.1%.
Earnings
Next report: 2026-10-28 · after close · EPS est 0.13
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-07-29 | 0.58 | 0.59 | +1.9% |
| 2026-04-29 | 0.53 | 0.49 | -7.8% |
| 2026-02-05 | 0.55 | 1.60 | +189.6% |
| 2025-10-29 | 0.30 | 0.24 | -19.9% |
| 2025-07-30 | 0.55 | 0.79 | +44.0% |
| 2025-04-30 | 0.45 | 0.69 | +54.3% |
| 2025-02-12 | 0.34 | 0.45 | +33.0% |
| 2024-10-30 | 0.61 | 0.54 | -11.0% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $4.5B | +1.0% |
| 2026-03-31 | $4.5B | – |
| 2025-12-31 | $4.6B | – |
| 2025-09-30 | $4.3B | – |
| 2025-06-30 | $4.4B | – |
Analyst actions
JP Morgan
PT $42
2026-10-20 · main
Overweight → OverweightPT $42
Stifel
PT $40
2026-10-20 · main
Hold → HoldPT $40
Truist Securities
PT $45
2026-10-20 · main
Buy → BuyPT $45
Morgan Stanley
PT $29
2026-10-19 · main
Underweight → UnderweightPT $29
Wells Fargo
PT $29
2026-10-19 · main
Equal-Weight → Equal-WeightPT $29
Macquarie
PT $48
2026-10-13 · main
Outperform → OutperformPT $48
Recent dividends
2022-12-08: $0.003 · 2022-09-08: $0.003 · 2022-06-09: $0.003 · 2022-03-09: $0.003 · 2021-12-09: $0.003 · 2021-09-09: $0.003 · 2021-06-09: $0.003 · 2021-03-09: $0.003
Insider trades
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
Stats refreshed 2026-10-20 18:08:46 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.